Forge Biologics
An Associate Scientist II at Forge Biologics develops, optimizes, and supports gene therapy manufacturing processes within the Manufacturing Science and Technology department. The role involves executing technology transfer activities, supporting documentation, and contributing to continuous improvement efforts in a cGMP environment.
Headquarters
Columbus, Ohio, United States
Company Size
201-500 employees
Founded
2020
Forge Biologics is a CDMO focused on accelerating gene therapy manufacturing, specializing in high‑yield adeno‑associated virus (AAV) vector production. The company offers end‑to‑end services including process and analytical development, clinical‑to‑commercial cGMP manufacturing at a world‑class facility, and regulatory and supply‑chain support. Clients partner with Forge for scalable AAV capacity, technical expertise, and seamless program support to move therapies faster toward patients.
Forge Biologics Emphasizes Safety Culture and EHSS Leadership
24 hours ago
The Progeria Research Foundation and Forge Biologics Announce Manufacturing Partnership to Advance Gene Therapy for Children with Progeria
1 week ago
May the Forge be with you: Ascidian partners with Forge Biologics to tackle Stargardt disease
Jan 13, 2026
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Forge Biologics.
6% above the average for this role
Ascidian Therapeutics, Forge Biologics Partner to Advance Stargardt Treatment
Jan 7, 2026
Senior Scientist - Injectable Drug Product Process Development
United States Postal Service
MSAT Senior Scientist, Biologics
Vertex
TS/MS Scientist - Dry EM
Validation & Engineering Group
OmniaBio: Associate Scientist (MSAT)
OmniaBio
Specialist MS&T
MSD
Senior Scientist, Drug Product Analytical Science And Technology (ASAT), Cell Therapy
Bristol Myers Squibb